365mc

What 365mc does

365mc is a Seoul-headquartered, privately held Korean medical services group that has built a 20+ branch specialty clinic network focused almost exclusively on adipose tissue treatments, including hospital-grade liposuction, a proprietary injection-based Local Anesthetic Minimal-Invasive Liposuction (LAMS) procedure, and an emerging adipose-derived stem cell (ADSC) therapeutics and banking franchise. Founded circa 2003 by chairman Kim Ha-jin and CEO Kim Nam-chul, the company has accumulated 377,052 liposuction procedures and 2,678,311 LAMS bottles as of 2026-05-31, with national scale covering Seoul (multiple districts), Incheon, Gyeonggi-do, Daejeon, Chungcheong, Daegu and Busan, and international locations in Indonesia (3 branches in Jakarta and Surabaya at Mayapada Hospital), Thailand (Bangkok, with Phuket in training), and the United States (Orange County, CA — opened September 2025).

The underlying technology stack is unusually deep for a clinic operator and rests on three proprietary platforms: (1) the LAMS lipolysis technique and LEPA 2.0 lipolysis solution; (2) the M.A.I.L AI-assisted liposuction planning system, the APPA post-symptom prediction algorithm, the Orange-i OR kiosk, and an ultra-precision AI skin-analysis device; and (3) a high-yield ADSC extraction and cryo-banking platform using a 36.5°C enzymatic process plus centrifugation that recovers 93%+ mesenchymal stem cells (100M live cells per 130cc of fat) and supports up to 25-year cryopreservation. The Gangnam Main Branch Stem Cell Center was designated as an Advanced Regenerative Medicine Implementation Institution by the Korean Ministry of Health and Welfare in November 2025, anchoring the company's regulatory credentials.

365mc earns revenue primarily on a per-procedure / per-bottle basis for liposuction and LAMS (₩12.5B from foreign patients alone, per News1), supplemented by per-program charges for ADSC therapies (Skin Shot, Hair Shot, Bio Shot IV, Hepagori, Baepagari) and recurring cryo-banking storage fees; a DTC skincare line (Pangpang Cream, launched March 2026) extends the ADSC IP into consumer products. Go-to-market is direct-to-consumer, with online "cost mail" lead capture, a multi-language booking funnel, paid digital marketing (Naver, Google, Kakao), TV/celebrity partnerships, and the official mobile app driving patient acquisition into in-clinic coordinator-led conversion across all branches.

Name

365mc

Legal name

(주)365mc [365mc Inc.] — Korean corporate designation (주식회사) registered under business registration No. 120-87-04354, representative Kim Nam-chul (김남철), at 3~4F Jeil Building, 7 Seochodaero 52-gil, Seocho-gu, Seoul, South Korea

Website

https://365mc.co.kr

Company type

Private

Founded year

2003

Operating status

Operating

Short description

365mc is a Korean specialty clinic operator and medical technology company that delivers proprietary liposuction, LAMS injection lipolysis, and adipose-derived stem cell therapies through a 20+ branch domestic network and international locations in Indonesia, Thailand, and the United States.

Ownership category

akta.pro rank

Headquarters

HQ city

Seoul

HQ country

South Korea

HQ region

Asia

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Liposuction Surgical Fees: Per-procedure one-time charges for hospital-grade liposuction, performed across 18+ domestic and 5+ international branches. Pricing is quote-based per body part (abdomen, thighs, arms, calves, face) and per hospital/doctor. Total cumulative liposuction cases: 377,052 (2026-05-31).
2. LAMS (Local Anesthetic Minimal-Invasive Liposuction) Treatment Fees: Per-bottle / per-area charges for LAMS, the proprietary local-anesthesia injection-based fat removal procedure. Cumulative LAMS bottles administered: 2,678,311 (2026-05-31).
3. Stem Cell Programs & Banking: Per-procedure charges for stem cell programs (Skin Shot, Hair Shot, Bio Shot IV, Herpagori, Baepagari) plus recurring-style stem cell banking subscription/storage. Designated Advanced Regenerative Medicine Institution by the Korean Ministry of Health and Welfare.
4. DTC Skincare Products (Pangpang Cream): Direct-to-consumer sales of cosmetic line '팽팽크림' (Pangpang Cream) leveraging cultured ADSC conditioned media; launched for general consumer use on 2026-03-09.
5. Practice Index (실천지수) Membership Loyalty: Non-cash behavioral reward system that supports repeat visits and cross-branch usage; functions as a discount/loyalty layer across all branches.
6. Global / International Medical Services: Per-procedure charges from international branches in Indonesia (3), Thailand (Bangkok), and USA (LA, Orange County), plus inbound foreign-patient revenue from China, Russia, Southeast Asia, etc. Foreign patients spent ₩12.5B at 365mc (per News1, 2026-06-02).

Pricing tiers

Go-to-market motion4 records

Core offering

365mc is a Korean specialty medical-services provider that performs hospital-grade liposuction surgery and its proprietary LAMS (Local Anesthetic Minimal-Invasive Liposuction) fat-dissolving injection procedure, alongside an adipose-derived stem cell program suite (Skin Shot, Hair Shot, Bio Shot IV, Hepagori body contouring, Baepagari breast fat grafting) and long-term cryogenic stem cell banking. Services are delivered through 18+ directly owned clinics in Korea and international branches in the United States, Indonesia, and Thailand, with procedure volumes of 377,052 liposuction surgeries and 2,678,311 LAMS bottles as of 2026-05-31.

Differentiator

Problem solved

Functional benefit

Brands

• 팽팽크림 (Pangpang Cream): Premium cosmetic body-firming cream line launched in March 2026, based on 365mc's cultured human adipose-derived stem cell (ADSC) extract — 365mc's first consumer cosmetic brand outside its clinic services.
• 팽팽클리닉 (Pangpang Clinic)
• LAMS (람스) — Local Anesthetic Minimal-Invasive Liposuction
• dca밉살주사 (dca Mesofat Injection)

Products and services

• LAMS (Local Anesthetic Minimal-Invasive Liposuction / 람스) 365mc's signature fat-removal injection procedure performed under local anesthesia without surgical incision or general anesthesia, enabling same-day return to daily activities. Targeted at consumers seeking minimally invasive removal of stubborn localized fat across body parts (abdomen, thighs, arms, calves, face).
• Liposuction Surgery (지방흡입) Hospital-grade liposuction surgery performed under general anesthesia with body-part-specific protocols and AI-assisted planning (M.A.I.L system) plus LEPA 2.0 lipolysis solution. For adults seeking large-volume or surgical-grade fat removal.
• DCA Mipsal Injection (dca밉살주사) Fat-dissolving mesotherapy injection for stubborn facial fat (double chin, jowl, lower-cheek areas). Marketed as a non-liposuction fat-destruction treatment and offered nationwide across all 365mc branches.
• Adipose Stem Cell Skin Shot (지방줄기세포 스킨샷) Autologous adipose-derived stem cell injection into the dermal layer to improve wrinkles, elasticity, redness, and skin tone. Positioned as 'anti-aging care rooted in one's own fat' for adult consumers seeking regenerative skin rejuvenation.
• Adipose Stem Cell Hair Shot (지방줄기세포 헤어샷) Autologous adipose-derived stem cell scalp injection to reactivate weakened hair follicles, promote hair growth, and improve scalp health. Performed under local cryo-anesthesia for pain reduction. Targeted at adults with thinning hair or hair loss.
• Adipose Stem Cell Bio Shot IV (지방줄기세포 바이오샷) High-yield autologous adipose-derived stem cell intravenous therapy for whole-body tissue regeneration, fatigue recovery, vitality boost, blood circulation improvement, immunity enhancement, and systemic anti-aging effects.
• Adipose Stem Cell Hepagori (지방줄기세포 허파고리) Body contouring program combining LAMS fat removal with stem-cell-enriched fat transplantation for high-engraftment, long-lasting S-line pelvis volume and hip-up effect. Improves body volume, skin elasticity, and recovery time.
• Adipose Stem Cell Baepagari (지방줄기세포 배파가리) No-incision, no-implant breast augmentation combining LAMS abdominal fat removal with stem-cell-enriched autologous fat grafting into the breasts via injection. Marketed as 'the new standard of breast surgery' for natural-volume breast enhancement without implants. Variants include the original liposuction-based Baepagari, the LAMS-based stem-cell Baepagari, and Baepagari LAMS.
• Adipose Stem Cell Banking (지방줄기세포 뱅킹) Cryogenic storage subscription for autologous adipose-derived mesenchymal stem cells extracted by 365mc's patented 36.5°C enzymatic process. Yields up to 100 million live cells per 130cc of fat with stable storage for up to 25 years, allowing future anti-aging and regenerative use.
• Adipose Stem Cell Custom Shot (지방줄기세포 커스텀샷) Customizable autologous adipose-derived stem cell injection program that lets the customer choose the target treatment area (face, scalp, skin, body) for personalized regenerative therapy.
• CoreSculpt (코어스컬프) Non-invasive 30-minute body contouring treatment using high-intensity focused magnetic energy to deliver the equivalent of 36,000 exercise repetitions, combining core muscle strengthening with subcutaneous fat reduction. For adults seeking muscle toning and fat reduction without surgery or downtime.
• Pangpang Cream (팽팽크림) Premium DTC body-firming cosmetic cream leveraging 365mc's cultured human adipose-derived stem cell (ADSC) conditioned media to strengthen the skin barrier, improve elasticity, and reduce fine lines. Distributed directly to general consumers through 365mc's bio business division.

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability9 records

Feature12 records

Recent moves3 records

Expansion highlights5 records

Broad incumbents

• AbbVie (Allergan Aesthetics): Global aesthetics incumbent owning CoolSculpting and other body-contouring devices that compete with 365mc's CoreSculpt and LAMS offerings. Comparable as an established player in the broader non-invasive and minimally invasive body-contouring market.

Emerging players

• Celltex Therapeutics: US-based autologous adult stem cell banking and therapy company. Comparable to 365mc's Stem Cell Banking division in business model, though operating under different US regulatory frameworks for stem cell services.

Direct peers

• View Plastic Surgery: Seoul-based cosmetic surgery clinic focusing on body contouring, liposuction and facial procedures. Comparable to 365mc Gangnam in target customer and procedure mix.
• ID Hospital: Large Korean plastic/cosmetic surgery hospital chain offering liposuction, body contouring and facial procedures to domestic and inbound medical-tourism patients. Directly comparable as a multi-branch Korean aesthetic hospital serving foreign patients.
• Grand Plastic Surgery: Korean plastic surgery clinic network competing directly with 365mc in body-contouring and liposuction services, including LAMS-adjacent offerings and medical-tourism patient acquisition.
• BK Plastic Surgery: Korean multi-branch cosmetic surgery group with active medical-tourism marketing in China, Japan and Southeast Asia. Comparable in clinic-network scale and inbound patient model to 365mc.
• Wonjin Plastic Surgery: Korean cosmetic-surgery clinic offering liposuction and body-contouring programs, with a strong inbound patient base from East Asia. Comparable in procedure mix and customer profile to 365mc.
• The Plastic Surgery Clinic: Korean cosmetic surgery network with strong medical-tourism and Chinese-language marketing focus. Comparable in procedure range and cross-border patient acquisition model to 365mc.
• Lydian Plastic Surgery: Korean premium-positioned cosmetic surgery clinic with body-contouring expertise and foreign-patient services. Comparable as a high-end single-specialty aesthetic clinic competing for the same Korean and inbound patient pool.

Others

• Marathon Pharmaceuticals: Korean pharmaceutical/regenerative-medicine player adjacent to 365mc's stem cell therapy expansion. Comparable as a Korean ecosystem participant in the regenerative-medicine supply chain, though not a direct procedure competitor.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/user/365mc1
• Instagraminstagram.com/365mc_jibang2
• Xx.com/korea365mc
• Facebookfacebook.com/365mc

Compliance6 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Subsidiaries25 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about 365mc